Agreed. I'm glad NP issued a PR on cancer. With so much focus on COVID (rightly so), at some point it will start to fade, and people need to understand that leronlimab is not just a COVID drug. It's so much more (referring to the list Ohm put together). Yes, COVID got our foot in the door for awareness to the general public, but cancer and HIV will be the backbone on this company. Strike while the iron is hot....and NP is doing that with sprinkling cancer updates into the PR's and hopefully the BLA announcement next week!